(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with idarubicin in 1 studies
| Studies ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Trials ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Recent Studies (post-2010) ((3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium) | Studies (idarubicin) | Trials (idarubicin) | Recent Studies (post-2010) (idarubicin) |
|---|---|---|---|---|---|
| 52 | 3 | 1 | 1,795 | 454 | 487 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuello, MT; González-Cid, M; Karara, A; Larripa, I; Nebel, Mde C; Vellón, L | 1 |
1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and idarubicin
| Article | Year |
|---|---|
Enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in K-562 cell line.
Topics: Apoptosis; Biological Transport; Cations; Cholesterol; Comet Assay; DNA Damage; DNA, Neoplasm; Drug Synergism; Flow Cytometry; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Idarubicin; K562 Cells; Lipids; Liposomes; Microscopy, Fluorescence; Neoplasm Proteins; Oligodeoxyribonucleotides, Antisense; Phosphatidylethanolamines; Quaternary Ammonium Compounds; RNA, Messenger; RNA, Neoplasm | 2002 |